RecruitingNCT06991881
Eosinophilic Esophagitis: Towards Improved Management
Studying Primary eosinophilic gastrointestinal disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oslo University Hospital
- Principal Investigator
- Ketil Størdal, PhDUniversity of Oslo
- Intervention
- Biobank sampling for new biomarkers(other)
- Enrollment
- 80 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2023 – 2025
Study locations (2)
- Haukeland University Hospital, Bergen, Norway
- OsloUH, Oslo, Norway
Collaborators
Helse-Bergen HF
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06991881 on ClinicalTrials.govOther trials for Primary eosinophilic gastrointestinal disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06851559A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksPhathom Pharmaceuticals, Inc.
- RECRUITINGNANCT06817213Patient-Centered Decision Support for Eosinophilic EsophagitisUniversity of Michigan
- RECRUITINGNCT06695897A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in GermanySanofi
- ACTIVE NOT RECRUITINGPHASE4NCT06352073Dupilumab for Eosinophilic Esophagitis With Severe StricturesUniversity of North Carolina, Chapel Hill
- RECRUITINGNANCT06381219Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot TrialUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGNANCT06501274Capsule Sponge Study in Eosinophilic OesophagitisEast and North Hertfordshire NHS Trust
- RECRUITINGNANCT05730933An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- RECRUITINGPHASE1, PHASE2NCT05608681A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).Eupraxia Pharmaceuticals Inc.
See all trials for Primary eosinophilic gastrointestinal disease →